端粒
肾细胞癌
医学
基因型
端粒酶逆转录酶
单核苷酸多态性
肿瘤科
等位基因
内科学
肿瘤进展
生物标志物
疾病
癌症研究
端粒酶
遗传学
生物
癌症
DNA
基因
作者
Mariana Morais,Francisca Dias,Telma Resende,Inês Nogueira,Jorge Oliveira,Joaquina Maurício,Ana Luísa Teixeira,Rui Medeiros
出处
期刊:Future Oncology
[Future Medicine]
日期:2020-05-18
卷期号:16 (18): 1245-1255
被引量:4
标识
DOI:10.2217/fon-2019-0795
摘要
Aim: Analysis of the genetic hTERT-1327 C>T (rs2735940) influence on leukocyte telomere length (LTL) and tumor development, progression and overall survival in renal cell carcinoma (RCC) patients. Materials & methods: Using leukocyte DNA of RCC patients and healthy individuals, LTL measurement and allelic discrimination of rs2735940 was performed by real-time PCR. Results: RCC patients showed shorter LTL than healthy individuals and LTL increased with clinical stage. CC+TC genotypes healthy carriers' presented shorter LTL. However, no statistical association between the different genotypes and RCC risk. Nevertheless, CC homozygous presented a reduced time to disease progression and a lower overall survival. The use of hTERT-1327 single nucleotide polymorphism information increased the capacity to predict risk for RCC progression. Conclusion: In fact, in healthy individuals, hTERT-1327 CC+TC genotypes were associated with shorter LTL, and this single nucleotide polymorphism was associated with time to disease progression, being a promising potential prognosis biomarker to be used in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI